{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:09:33Z","timestamp":1791126573297,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12325-023-02657-0","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:02:14Z","timestamp":1695888134000},"page":"5137-5154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-5975","authenticated-orcid":false,"given":"Sergio","family":"Gianesini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-1272","authenticated-orcid":false,"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Feodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-181X","authenticated-orcid":false,"given":"Wassila","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kursat","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0644-0560","authenticated-orcid":false,"given":"Fedor","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2657_CR1","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1093\/eurheartj\/ehab589","volume":"42","author":"NM Hamburg","year":"2021","unstructured":"Hamburg NM. The legs are a pathway to the heart: connections between chronic venous insufficiency and cardiovascular disease. Eur Heart J. 2021;42:4166\u20138.","journal-title":"Eur Heart J"},{"key":"2657_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1358863X20953212","volume":"25","author":"M Halkar","year":"2020","unstructured":"Halkar M, Medina Inojosa J, Liedl D, et al. Calf muscle pump function as a predictor of all-cause mortality. Vasc Med. 2020;25:519\u201326.","journal-title":"Vasc Med"},{"key":"2657_CR3","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehab495","volume":"42","author":"JH Prochaska","year":"2021","unstructured":"Prochaska JH, Arnold N, Falcke A, et al. Chronic venous insufficiency, cardiovascular disease, and mortality: a population study. Eur Heart J. 2021;42:4157\u201365.","journal-title":"Eur Heart J"},{"key":"2657_CR4","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1007\/s00330-020-06696-x","volume":"30","author":"F Ammermann","year":"2020","unstructured":"Ammermann F, Meinel FG, Beller E, et al. Concomitant chronic venous insufficiency in patients with peripheral artery disease: insights from MR angiography. Eur Radiol. 2020;30:3908\u201314.","journal-title":"Eur Radiol"},{"key":"2657_CR5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/SLA.0000000000004631","volume":"274","author":"S Salim","year":"2021","unstructured":"Salim S, Machin M, Patterson BO, Onida S, Davies AH. Global epidemiology of chronic venous disease: a systematic review with pooled prevalence analysis. Ann Surg. 2021;274:971\u20136.","journal-title":"Ann Surg"},{"key":"2657_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.113.006898","volume":"130","author":"RT Eberhardt","year":"2014","unstructured":"Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333\u201346.","journal-title":"Circulation"},{"key":"2657_CR7","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/jocd.14337","volume":"21","author":"F K\u0131l\u0131n\u00e7","year":"2022","unstructured":"K\u0131l\u0131n\u00e7 F, Akba\u015f A, \u015eener S, Hayran Y, Akta\u015f A. Cutaneous findings in patients with chronic venous insufficiency. J Cosmet Dermatol. 2022;21:2106\u201312.","journal-title":"J Cosmet Dermatol"},{"key":"2657_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jvsv.2019.12.075","volume":"8","author":"F Lurie","year":"2020","unstructured":"Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8:342\u201352.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"2657_CR9","first-page":"117","volume":"52","author":"A Mironiuc","year":"2011","unstructured":"Mironiuc A, Palcau L, Rogojan L, Micula S, Gherman C. Is there a correlation between the CEAP score and the histopathological findings in varicose disease? Rom J Morphol Embryol. 2011;52:117\u201321.","journal-title":"Rom J Morphol Embryol"},{"key":"2657_CR10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1549-8719.2000.tb00145.x","volume":"7","author":"M J\u00fcnger","year":"2010","unstructured":"J\u00fcnger M, Steins A, Hahn M, H\u00e4fner H-M. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation. 2010;7:S3\u201312.","journal-title":"Microcirculation"},{"key":"2657_CR11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0741-5214(98)70051-5","volume":"28","author":"CJ Evans","year":"1998","unstructured":"Evans CJ, Allan PL, Lee AJ, Bradbury AW, Ruckley CV, Fowkes FG. Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh Vein Study. J Vasc Surg. 1998;28:767\u201376.","journal-title":"J Vasc Surg"},{"key":"2657_CR12","volume":"10","author":"NC Wu","year":"2020","unstructured":"Wu NC, Chen ZC, Feng IJ, et al. Severe varicose veins and the risk of mortality: a nationwide population-based cohort study. BMJ Open. 2020;10: e034245.","journal-title":"BMJ Open"},{"key":"2657_CR13","first-page":"452","volume":"28","author":"LA M\u00e4kivaara","year":"2009","unstructured":"M\u00e4kivaara LA, Ahti TM, Luukkaala T, Hakama M, Laurikka JO. The risk of congestive heart failure is increased in persons with varicose veins. Int Angiol. 2009;28:452\u20137.","journal-title":"Int Angiol"},{"key":"2657_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.2018.0246","volume":"319","author":"SL Chang","year":"2018","unstructured":"Chang SL, Huang YL, Lee MC, et al. Association of varicose veins with incident venous thromboembolism and peripheral artery disease. JAMA. 2018;319:807\u201317.","journal-title":"JAMA"},{"key":"2657_CR15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.117.031062","volume":"137","author":"I Cavallari","year":"2018","unstructured":"Cavallari I, Morrow DA, Creager MA, et al. Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis. Circulation. 2018;137:684\u201392.","journal-title":"Circulation"},{"key":"2657_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.carpath.2018.04.004","volume":"35","author":"IS de Macedo","year":"2018","unstructured":"de Macedo IS, Dinardi LFL, Pereira TV, et al. Thromboembolic findings in patients with heart failure at autopsy. Cardiovasc Pathol. 2018;35:23\u20138.","journal-title":"Cardiovasc Pathol"},{"key":"2657_CR17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2019.10.058","volume":"75","author":"CL Fanola","year":"2020","unstructured":"Fanola CL, Norby FL, Shah AM, et al. Incident heart failure and long-term risk for venous thromboembolism. J Am Coll Cardiol. 2020;75:148\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"2657_CR18","volume":"5","author":"CN Hess","year":"2022","unstructured":"Hess CN, Szarek M, Anand SS, et al. Rivaroxaban and risk of venous thromboembolism in patients with symptomatic peripheral artery disease after lower extremity revascularization. JAMA Netw Open. 2022;5: e2215580.","journal-title":"JAMA Netw Open"},{"key":"2657_CR19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.113.003126","volume":"130","author":"A Mebazaa","year":"2014","unstructured":"Mebazaa A, Spiro TE, B\u00fcller HR, et al. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure. Circulation. 2014;130:410\u20138.","journal-title":"Circulation"},{"key":"2657_CR20","doi-asserted-by":"crossref","first-page":"107602961983805","DOI":"10.1177\/1076029619838052","volume":"25","author":"M Cronin","year":"2019","unstructured":"Cronin M, Dengler N, Krauss ES, et al. Completion of the updated Caprini Risk Assessment Model (2013 Version). Clin Appl Thromb Hemost. 2019;25:1076029619838052.","journal-title":"Clin Appl Thromb Hemost"},{"key":"2657_CR21","first-page":"374","volume":"35","author":"M Perrin","year":"2016","unstructured":"Perrin M, Ekl\u00f6f B, Rij AV, et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35:374\u201398.","journal-title":"Int Angiol"},{"key":"2657_CR22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0268355515591394","volume":"31","author":"A\u00c7 Aykan","year":"2016","unstructured":"Aykan A\u00c7, Mente\u015fe S, Do\u011fan E, et al. Assessment of arterial stiffness in patients with chronic lower extremity venous disease: an observational study. Phlebology. 2016;31:349\u201355.","journal-title":"Phlebology"},{"key":"2657_CR23","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.20781","volume":"18","author":"M Matic","year":"2016","unstructured":"Matic M, Matic A, Djuran V, Gajinov Z, Prcic S, Golusin Z. Frequency of peripheral arterial disease in patients with chronic venous insufficiency. Iran Red Crescent Med J. 2016;18: e20781.","journal-title":"Iran Red Crescent Med J"},{"key":"2657_CR24","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2014.04.049","volume":"60","author":"TF O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell TF, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery\u00ae and the American Venous Forum. J Vasc Surg. 2014;60:3S-59S.","journal-title":"J Vasc Surg"},{"key":"2657_CR25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejvs.2021.12.024","volume":"63","author":"MG De Maeseneer","year":"2022","unstructured":"De Maeseneer MG, Kakkos SK, Aherne T, et al. Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63:184\u2013267.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2657_CR26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jvs.2007.06.044","volume":"46","author":"PH Carpentier","year":"2007","unstructured":"Carpentier PH, Poulain C, Fabry R, et al. Ascribing leg symptoms to chronic venous disorders: the construction of a diagnostic score. J Vasc Surg. 2007;46:991\u20136.","journal-title":"J Vasc Surg"},{"key":"2657_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2019.11.028","volume":"75","author":"SZ Goldhaber","year":"2020","unstructured":"Goldhaber SZ. Venous thromboembolism in heart failure patients: pathophysiology, predictability, prevention. J Am Coll Cardiol. 2020;75:159\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"2657_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2796.2007.01815.x","volume":"262","author":"P Prandoni","year":"2007","unstructured":"Prandoni P. Links between arterial and venous disease. J Intern Med. 2007;262:341\u201350.","journal-title":"J Intern Med"},{"key":"2657_CR29","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/ijms19061669","volume":"19","author":"A Mansilha","year":"2018","unstructured":"Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19:1669.","journal-title":"Int J Mol Sci"},{"key":"2657_CR30","doi-asserted-by":"publisher","unstructured":"Dardi P, Dos Reis Costa DEF, Assuncao HCR, Rossoni LV. Venous endothelial function in cardiovascular disease. 2022. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20220285.","DOI":"10.1042\/BSR20220285"},{"key":"2657_CR31","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/473765","volume":"2014","author":"V Tisato","year":"2014","unstructured":"Tisato V, Zauli G, Gianesini S, et al. Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction. J Immunol Res. 2014;2014: 473765.","journal-title":"J Immunol Res"},{"key":"2657_CR32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/01.CIR.0000022846.22923.46","volume":"106","author":"P Sansilvestri-Morel","year":"2002","unstructured":"Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation. 2002;106:479\u201383.","journal-title":"Circulation"},{"key":"2657_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0741-5214(93)90109-Y","volume":"17","author":"LS Wilkinson","year":"1993","unstructured":"Wilkinson LS, Bunker C, Edwards JC, Scurr JH, Smith PD. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 1993;17:669\u201375.","journal-title":"J Vasc Surg"},{"key":"2657_CR34","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0741-5214(97)70091-0","volume":"26","author":"PJ Pappas","year":"1997","unstructured":"Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg. 1997;26:784\u201395.","journal-title":"J Vasc Surg"},{"key":"2657_CR35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.23736\/S0392-9590.21.04726-X","volume":"40","author":"FZ Cyrino","year":"2021","unstructured":"Cyrino FZ, Blanc-Guillemaud V, Bouskela E. Time course of microvalve pathophysiology in high pressure low flow model of venous insufficiency and the role of micronized purified flavonoid fraction. Int Angiol. 2021;40:388\u201394.","journal-title":"Int Angiol"},{"key":"2657_CR36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ejvs.2018.02.009","volume":"55","author":"M das Gra\u00e7as C de Souza","year":"2018","unstructured":"das Gra\u00e7as C de Souza M, Cyrino FZ, de Carvalho JJ, Blanc-Guillemaud V, Bouskela E. Protective effects of micronized purified flavonoid fraction (MPFF) on a novel experimental model of chronic venous hypertension. Eur J Vasc Endovasc Surg. 2018;55:694\u2013702.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2657_CR37","first-page":"169","volume":"37","author":"M Lugli","year":"2018","unstructured":"Lugli M, Maleti O, Iabichella ML, Perrin M. Investigation of non-saphenous veins in C0S patients. Int Angiol. 2018;37:169\u201375.","journal-title":"Int Angiol"},{"key":"2657_CR38","unstructured":"Lugli M, Longhi M, Guerzoni S, Maleti O. Effect of micronized purified flavonoid fraction treatment on microscopic venous valves reflux in C0s and C1s patients with chronic venous disease. In: 21st Annual Meeting of the European Venous Forum; 2021."},{"key":"2657_CR39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejvs.2014.05.017","volume":"48","author":"LA Robertson","year":"2014","unstructured":"Robertson LA, Evans CJ, Lee AJ, Allan PL, Ruckley CV, Fowkes FG. Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. Eur J Vasc Endovasc Surg. 2014;48:208\u201314.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2657_CR40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/path.819","volume":"193","author":"C Badier-Commander","year":"2001","unstructured":"Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol. 2001;193:398\u2013407.","journal-title":"J Pathol"},{"key":"2657_CR41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","volume":"17","author":"C Rask-Madsen","year":"2013","unstructured":"Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20\u201333.","journal-title":"Cell Metab"},{"key":"2657_CR42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0268355519870690","volume":"34","author":"S Gianesini","year":"2019","unstructured":"Gianesini S, Obi A, Onida S, et al. Global guidelines trends and controversies in lower limb venous and lymphatic disease: narrative literature revision and experts\u2019 opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23\u201325 January 2019. Phlebology. 2019;34:4\u201366.","journal-title":"Phlebology"},{"key":"2657_CR43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","volume":"49","author":"C Wittens","year":"2015","unstructured":"Wittens C, Davies AH, B\u00e6kgaard N, et al. Editor\u2019s Choice\u2014management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49:678\u2013737.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2657_CR44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","volume":"37","author":"A Nicolaides","year":"2018","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37:181\u2013254.","journal-title":"Int Angiol"},{"key":"2657_CR45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/14659891.2011.615002","volume":"18","author":"RJ Cooper","year":"2013","unstructured":"Cooper RJ. Over-the-counter medicine abuse\u2014a review of the literature. J Subst Use. 2013;18:82\u2013107.","journal-title":"J Subst Use"},{"key":"2657_CR46","doi-asserted-by":"crossref","first-page":"vii54","DOI":"10.1093\/rheumatology\/key109","volume":"57","author":"S Monti","year":"2018","unstructured":"Monti S, Grosso V, Todoerti M, Caporali R. Randomized controlled trials and real-world data: differences and similarities to untangle literature data. Rheumatology (Oxford). 2018;57:vii54\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"2657_CR47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clinthera.2022.01.012","volume":"44","author":"L Burns","year":"2022","unstructured":"Burns L, Roux NL, Kalesnik-Orszulak R, et al. Real-world evidence for regulatory decision-making: guidance from around the world. Clin Ther. 2022;44:420\u201337.","journal-title":"Clin Ther"},{"key":"2657_CR48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s40267-019-00637-5","volume":"35","author":"V Bogachev","year":"2019","unstructured":"Bogachev V, Jim\u00e9nez Arribas JM, Baila S, et al. Management and evaluation of treatment adherence and effectiveness in chronic venous disorders: results of the international study VEIN Act Program. Drugs Ther Perspect. 2019;35:396\u2013404.","journal-title":"Drugs Ther Perspect"},{"key":"2657_CR49","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s12325-020-01270-9","volume":"37","author":"AV Chupin","year":"2020","unstructured":"Chupin AV, Katorkin SE, Katelnitsky II, et al. Sulodexide in the treatment of chronic venous insufficiency: results of the all-Russian multicenter ACVEDUCT program. Adv Ther. 2020;37:2071\u201382.","journal-title":"Adv Ther"},{"key":"2657_CR50","first-page":"1666","volume":"34","author":"JJ Guex","year":"2008","unstructured":"Guex JJ, Enrici E, Boussetta S, Avril L, Lis C, Taieb C. Correlations between ankle circumference, symptoms, and quality of life demonstrate the clinical relevance of minimal leg swelling reduction: results of a study in 1,036 Argentinean patients. Dermatol Surg. 2008;34:1666\u201375.","journal-title":"Dermatol Surg"},{"key":"2657_CR51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/000331970205300301","volume":"53","author":"G Jantet","year":"2002","unstructured":"Jantet G, RELIEF Study Group. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Angiology. 2002;53:245\u201356.","journal-title":"Angiology"},{"key":"2657_CR52","first-page":"140","volume":"18","author":"F Pitsch","year":"2011","unstructured":"Pitsch F. Results of the DECIDE survey: appraisal of the predictive value for chronic venous disease of a symptom checklist. Phlebolymphology. 2011;18:140\u20138.","journal-title":"Phlebolymphology"},{"key":"2657_CR53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.17116\/flebo202014031230","volume":"14","author":"YM Stoyko","year":"2020","unstructured":"Stoyko YM, Tsyplyashchuk AV, Kryzhanovsky SM. Diosmin therapy for chronic vein diseases in outpatient settings: results of non-intervention STATUS study. Flebologiya. 2020;14:230\u20136.","journal-title":"Flebologiya"},{"key":"2657_CR54","first-page":"68","volume":"28","author":"TM Zoubida","year":"2021","unstructured":"Zoubida TM, Ulloa JH. VEIN STEP: chronic VEnous dIsorders maNagement and treatment effectiveness evaluation in chronic venous disease, an international observational prospective study. Results from Morocco. Phlebolymphology. 2021;28:68\u201378.","journal-title":"Phlebolymphology"},{"key":"2657_CR55","first-page":"3","volume":"37","author":"ZT Mezalek","year":"2022","unstructured":"Mezalek ZT, Chen Z, Feodor T. VEINSTEP: chronic venous disorders management and treatment effectiveness evaluation in chronic venous disease, an international observational prospective study. Results from Morocco, China and Romania (Abstract and oral presentation for the UIP XIX World Congress of Phlebology, 12\u201316 September 2022, Istanbul, Turkey). Phlebology. 2022;37:3\u2013276.","journal-title":"Phlebology"},{"key":"2657_CR56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejvs.2014.11.006","volume":"49","author":"SK van der Velden","year":"2015","unstructured":"van der Velden SK, Pichot O, van den Bos RR, Nijsten TE, De Maeseneer MG. Management strategies for patients with varicose veins (C2\u2013C6): results of a worldwide survey. Eur J Vasc Endovasc Surg. 2015;49:213\u201320.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2657_CR57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.23736\/S0392-9590.20.04388-6","volume":"39","author":"A Nicolaides","year":"2020","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part II. Int Angiol. 2020;39:175\u2013240.","journal-title":"Int Angiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02657-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:08:37Z","timestamp":1698404917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02657-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2657"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02657-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Toni Feodor has received honoraria for speaking engagements from Servier, Medtronic and Alfasigma. Wassila Taha has received honoraria for speaking engagements from Servier and for executive committee\/advisory board engagements from ECoP. All authors (Sergio Gianesini, Leonardo De Luca, Toni Feodor, Wassila Taha, Kursat Bozkurt, and Fedor Lurie) received an honorarium from Servier, France, for their participation in the symposium.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}